Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2022 · Cancer Epidemiology Biomarkers & Prevention · 29 citations
https://doi.org/10.1158/1055-9965.epi-21-1287
Y
Yelena Kemel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
246
Papers
3.8K
Citations
29
h-index
50
i10-index
Yelena Kemel is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & BRCA gene mutations in cancer. The author has an h-index of 29, co-authored 210 publications.
ORCID: 0000-0002-5042-5651Papers by this author
worksClinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
2023 · JNCI Journal of the National Cancer Institute · 28 citations
https://doi.org/10.1093/jnci/djad186
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series
2024 · European Journal of Human Genetics · 3 citations
https://doi.org/10.1038/s41431-024-01623-w
Additional file 3 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20495866
Additional file 1 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20495860
Additional file 2 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20495863
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat